These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life. Djavan B Urology; 2003 Sep; 62(3 Suppl 1):6-14. PubMed ID: 12957195 [TBL] [Abstract][Full Text] [Related]
6. [Update on current care guidelines: benign prostatic hyperplasia]. Tammela T; Nurmi M; Pétas A; Sipilä R; Taari K Duodecim; 2012; 128(10):1046-7. PubMed ID: 22724320 [TBL] [Abstract][Full Text] [Related]
7. BPH update: medical versus interventional management. Blankstein U; Van Asseldonk B; Elterman DS Can J Urol; 2016 Feb; 23(Suppl 1):10-5. PubMed ID: 26924590 [TBL] [Abstract][Full Text] [Related]
8. Management of Benign Prostatic Hyperplasia. Kim EH; Larson JA; Andriole GL Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999 [TBL] [Abstract][Full Text] [Related]
9. Management of benign prostatic hyperplasia by family physicians. Toguri A; Barkin J Can J Urol; 2010 Feb; 17 Suppl 1():26-34. PubMed ID: 20170598 [TBL] [Abstract][Full Text] [Related]
10. Impact of medical therapy on transurethral resection of the prostate: two decades of change. Izard J; Nickel JC BJU Int; 2011 Jul; 108(1):89-93. PubMed ID: 20883490 [TBL] [Abstract][Full Text] [Related]
11. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F; Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia. Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705 [TBL] [Abstract][Full Text] [Related]
13. Benign prostatic hyperplasia. Barry M; Roehrborn C Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703 [No Abstract] [Full Text] [Related]
14. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis. Morlock R; Goodwin B; Gomez Rey G; Eaddy M Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026 [TBL] [Abstract][Full Text] [Related]
17. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate. Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152 [TBL] [Abstract][Full Text] [Related]